Philadelphia Trust Company’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Hold |
2,700
| – | – | 0.03% | 191 |
|
|
2025
Q1 | $301K | Sell |
2,700
-14
| -0.5% | -$1.56K | 0.03% | 202 |
|
|
2024
Q4 | $264K | Hold |
2,714
| – | – | 0.02% | 209 |
|
|
2024
Q3 | $312K | Hold |
2,714
| – | – | 0.02% | 198 |
|
|
2024
Q2 | $289K | Hold |
2,714
| – | – | 0.02% | 184 |
|
|
2024
Q1 | $263K | Hold |
2,714
| – | – | 0.02% | 199 |
|
|
2023
Q4 | $274K | Hold |
2,714
| – | – | 0.03% | 187 |
|
|
2023
Q3 | $276K | Hold |
2,714
| – | – | 0.03% | 186 |
|
|
2023
Q2 | $274K | Sell |
2,714
-298
| -10% | -$30.1K | 0.03% | 196 |
|
|
2023
Q1 | $277K | Hold |
3,012
| – | – | 0.03% | 190 |
|
|
2022
Q4 | $273K | Hold |
3,012
| – | – | 0.03% | 190 |
|
|
2022
Q3 | $229K | Hold |
3,012
| – | – | 0.03% | 193 |
|
|
2022
Q2 | $255K | Hold |
3,012
| – | – | 0.03% | 186 |
|
|
2022
Q1 | $264K | Sell |
3,012
-200
| -6% | -$17.5K | 0.02% | 200 |
|
|
2021
Q4 | $281K | Hold |
3,212
| – | – | 0.02% | 207 |
|
|
2021
Q3 | $263K | Hold |
3,212
| – | – | 0.02% | 208 |
|
|
2021
Q2 | $293K | Hold |
3,212
| – | – | 0.02% | 205 |
|
|
2021
Q1 | $275K | Hold |
3,212
| – | – | 0.02% | 198 |
|
|
2020
Q4 | $303K | Hold |
3,212
| – | – | 0.02% | 182 |
|
|
2020
Q3 | $279K | Hold |
3,212
| – | – | 0.03% | 178 |
|
|
2020
Q2 | $281K | Hold |
3,212
| – | – | 0.03% | 157 |
|
|
2020
Q1 | $265K | Hold |
3,212
| – | – | 0.03% | 147 |
|
|
2019
Q4 | $304K | Hold |
3,212
| – | – | 0.03% | 176 |
|
|
2019
Q3 | $279K | Hold |
3,212
| – | – | 0.03% | 183 |
|
|
2019
Q2 | $293K | Sell |
3,212
-373
| -10% | -$34K | 0.03% | 186 |
|
|
2019
Q1 | $309K | Hold |
3,585
| – | – | 0.03% | 177 |
|
|
2018
Q4 | $276K | Sell |
3,585
-304
| -8% | -$23.4K | 0.03% | 160 |
|
|
2018
Q3 | $300K | Buy |
+3,889
| New | +$300K | 0.02% | 177 |
|